DEEP EXPERIENCE. SHARED COMMITMENT.
"We take a private equity approach to a sector that’s traditionally been dominated by venture and early-stage growth firms. We'll work very closely with management to improve the operations of the business, update the product portfolio and revamp the commercial organization. We provide the support and resources our portfolio companies need to succeed.”
19
active portfolio companies
+
1200
employees worldwide
3
AP-II Investments to Date
9
successful exits
news
Sep 01, 2021
Keystone Dental acquires Osteon Medical, raises $25m led by Nantahala
Accelmed Partners I portfolio company Keystone Dental Inc. announced the acquisition of Osteon Medical and the completion of a $25 million financing round led by Nantahala, with participation from Accelmed and Migdal Insurance.
Aug 30, 2021
CartiHeal to be acquired by Bioventus for $500 millionAccelmed Ventures portfolio company CartiHeal is being acquired by Bioventus for $350 million in upfront consideration and up to $500 million including earn-outs.
Aug 13, 2021
Robotic surgery co Memic agrees $1b valuation SPAC mergerMemic, a portfolio company of Accelmed, signed a definitive agreement for a SPAC merger with MedTech Acquisition Corporation (Nasdaq: MTAC) with an equity value at over $1 billion.
Aug 04, 2021
CartiHeal succeeds in clinical trial for cartilage treatmentCartiHeal released a study validating the clear clinical benefits of its Agili-C™ implant for the treatment of cartilage lesions in arthritic and non-arthritic joints. Accelmed was the first investor in CartiHeal.
Contact Us